Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Torti

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Hospital Infection|September 7, 2016
Is it time to move from standard to targeted surgical prophylaxis?A Quirino, C Torti, G Cortese, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2017
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from ItalyC Caudai, A Materazzi, F Saladini, et al.
AIDS and Behavior|January 8, 2025
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational StudyV Iannone, F Lombardi, A Ciccullo, et al.
Genetica|June 16, 2005
Cchobo, a hobo-related sequence in Ceratitis capitataC Torti, L M Gomulski, M Bonizzoni, et al.
HIV Medicine|July 30, 2010
The evolving burden of HIV infection compared with other chronic diseases in northern ItalyM Magoni, C Scarcella, F Vassallo, et al.
HIV Clinical Trials|October 30, 2003
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switchL R Tomasoni, A Patroni, C Torti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 18, 2015
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER CohortM C Postorino, M Prosperi, E Quiros-Roldan, et al.
Journal of Medical Virology|November 22, 2005
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitorsA Saracino, L Monno, L Scudeller, et al.
Genetics|March 10, 2001
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitataL M Gomulski, R J Pitts, S Costa, et al.
AIDS Patient Care and Stds|January 7, 2005
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patientsC Torti, E Quiros-Roldan, V Tirelli, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Hospital Infection|September 7, 2016
Is it time to move from standard to targeted surgical prophylaxis?A Quirino, C Torti, G Cortese, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 17, 2017
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from ItalyC Caudai, A Materazzi, F Saladini, et al.
AIDS and Behavior|January 8, 2025
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational StudyV Iannone, F Lombardi, A Ciccullo, et al.
Genetica|June 16, 2005
Cchobo, a hobo-related sequence in Ceratitis capitataC Torti, L M Gomulski, M Bonizzoni, et al.
HIV Medicine|July 30, 2010
The evolving burden of HIV infection compared with other chronic diseases in northern ItalyM Magoni, C Scarcella, F Vassallo, et al.
HIV Clinical Trials|October 30, 2003
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switchL R Tomasoni, A Patroni, C Torti, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 18, 2015
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER CohortM C Postorino, M Prosperi, E Quiros-Roldan, et al.
Journal of Medical Virology|November 22, 2005
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitorsA Saracino, L Monno, L Scudeller, et al.
Genetics|March 10, 2001
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitataL M Gomulski, R J Pitts, S Costa, et al.
AIDS Patient Care and Stds|January 7, 2005
Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patientsC Torti, E Quiros-Roldan, V Tirelli, et al.
Pageof 9